« Back to Record
Bleiberg, H., & Cvitkovic, E. (1996). Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: The European perspective. European journal of cancer, 32(SUPPL. 3), S18-S23.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/90328



